Inqovi
| Inqovi | |
|---|---|
| Term | Inqovi |
| Short definition | Inqovi (in-KOH-vee) A combination of decitabine and cedazuridine for the treatment of adults with myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Inqovi - (pronounced) (in-KOH-vee) A combination of decitabine and cedazuridine for the treatment of adults with myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Decitabine stops cells from making DNA, which can help prevent cancer cells from growing and kill them. Cedazuridine prevents decitabine from being broken down in the body, which allows more cancer cells to be killed. Inqovi is a type of antimetabolite and a type of cytidine deaminase inhibitor. Also called decitabine and cedazuridine
External links
- Medical encyclopedia article on Inqovi
- Wikipedia's article - Inqovi
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski